Gulf Pharmaceutical IndustriesGulf Pharmaceutical IndustriesGulf Pharmaceutical Industries

Gulf Pharmaceutical Industries

No trades
See on Supercharts
Market capitalization
‪1.09 B‬AED
−0.0858AED
‪−99.10 M‬AED
‪1.64 B‬AED
‪355.95 M‬
Beta (1Y)
1.50

About Gulf Pharmaceutical Industries

CEO
Basel Ziyadeh
Headquarters
Ras Al Khaymah
Founded
1980
ISIN
AEG000201018
FIGI
BBG000HLT7F1
Gulf Pharmaceutical Industries engages in the manufacture and sale of medicines, injections, and consumer healthcare products. It operates through the following segments: Manufacturing, Planet, Investments, and Others. The firm specializes in wound care, cardiovascular, diabetes solutions, and pain management. The company was founded by Saqr bin Mohammed Al-Qasimi on March 30, 1980 and is headquartered in Ras Al Khaymah, United Arab Emirates.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of JULPHAR is 0.9350 AED — it has decreased by 0.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ADX exchange Gulf Pharmaceutical Industries stocks are traded under the ticker JULPHAR.
JULPHAR stock is 1.83% volatile and has beta coefficient of 1.50. Check out the list of the most volatile stocks — is Gulf Pharmaceutical Industries there?
Yes, you can track Gulf Pharmaceutical Industries financials in yearly and quarterly reports right on TradingView.
JULPHAR stock has fallen by 3.41% compared to the previous week, the month change is a 2.71% fall, over the last year Gulf Pharmaceutical Industries has showed a 4.49% decrease.
JULPHAR net income for the last quarter is ‪−15.70 M‬ AED, while the quarter before that showed ‪−39.30 M‬ AED of net income which accounts for 60.05% change. Track more Gulf Pharmaceutical Industries financial stats to get the full picture.
Today Gulf Pharmaceutical Industries has the market capitalization of ‪1.09 B‬, it has decreased by 0.52% over the last week.
Like other stocks, JULPHAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gulf Pharmaceutical Industries stock right from TradingView charts — choose your broker and connect to your account.
JULPHAR reached its all-time high on Sep 26, 2013 with the price of 5.6968 AED, and its all-time low was 0.6516 AED and was reached on May 28, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Gulf Pharmaceutical Industries technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Gulf Pharmaceutical Industries stock shows the sell signal. See more of Gulf Pharmaceutical Industries technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Gulf Pharmaceutical Industries future price: according to them, JULPHAR price has a max estimate of 1.23 AED and a min estimate of 1.23 AED. Read a more detailed Gulf Pharmaceutical Industries forecast: see what analysts think of Gulf Pharmaceutical Industries and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Gulf Pharmaceutical Industries EBITDA is ‪93.00 M‬ AED, and current EBITDA margin is 5.68%. See more stats in Gulf Pharmaceutical Industries financial statements.